Shots:

• Paragon’s facility- Qlarity Imaging will lead the expansion of diagnostic applications of QuantX- with the additional ability of image modalities and medical conditions- improving patient care by advancing breast cancer diagnosis system in radiology
• The clinical study results assessing QuantX demonstrated a 39% reduction in missed breast cancers without a reduction in specificity and 20% overall diagnostic improvement
• QuantX is a computer-aided breast cancer diagnosis software for radiology and is the first FDA cleared AI breast cancer diagnostic tool

Click here to read full press release/ article | Ref: Paragon Biosciences | Image:Paragon Biosciences